OZEM vs THNR

Roundhill GLP-1 & Weight Loss ETF against Amplify Weight Loss Drug & Treatment ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
61%
14 shared positions
Fee gap
0 bp
same fee
1-year return gap
1.8 pts
OZEM is ahead
Larger fund
OZEM
$55M

Side by side

OZEMTHNR
FundRoundhill GLP-1 & Weight Loss ETFAmplify Weight Loss Drug & Treatment ETF
IssuerRoundhillAmplify
CategoryBiotech & Health InnovationGlobal
Expense ratio0.59%0.59%
Assets$55M$5.6M
Average daily dollar volume$493K$18K
ListedMay 20, 2024May 20, 2024
FrenzyCap score3322
1-month return−5.9%−4.6%
3-month return−9.6%−4.4%
Year to date−13.3%−2.8%
1-year return+1.4%−0.4%
30-day volatility20.4%19.2%
Worst drawdown, 1 year−20.9%−13.1%
Trailing 12-month yield1.39%1.69%
Holdings2621
Top 10 weight65.9%60.2%
Look-through P/E——
Holdings vs fair value+3.2%−1.7%
Holdings above 200-day average54%59%
Net flow, latest 3 reported months+$286K thru Jun 2026$0 thru Jun 2026
30-day implied volatility36.5%—
Holdings as ofas of Jun 30, 2026SEC filingas of Jun 30, 2026SEC filing

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

77% of OZEM · 67% of THNR
HoldingOZEMTHNR
NVO12.96%9.76%
LLY12.69%9.26%
VKTX5.86%5.49%
Chugai Pharmaceutical Co Ltd4.51%4.57%
CSPC Pharmaceutical Group Ltd5.32%4.48%
PFE6.38%4.39%
AMGN3.85%4.58%
AstraZeneca PLC3.83%4.56%
Zealand Pharma A/S3.92%3.48%
Roche Holding AG3.03%4.52%
KLRA6.21%2.46%
Innovent Biologics Inc2.37%5.00%
Jiangsu Hengrui Pharmaceutical2.58%2.27%
Hanmi Pharm Co Ltd3.50%2.00%

Sector mix of the stock holdings

SectorOZEMTHNRGap
Health Care57.2%66.5%−9.4%

More: full overlap table · OZEM holdings · THNR holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.